Focus on Deprenyl
The antiaging brain booster
D
eprenyl, also known as selegiline, was invented by The loss of dopamine
Professor Joseph Knoll in the 1960’s. It has been the in the brain has been
mainstay of Parkinson’s disease treatment to this day due to estimated at 13% per
its ability to enhance dopamine levels, a neurotransmitter decade past the age of
that is most affected in Parkinson’s. 40 for normal, aging
people. This decline
Deprenyl is one of only two is much faster for
products currently available, (the those with Parkinson’s
other being rasagiline, see page symptoms.
13) to selectively inhibit an enzyme
known as MAO-b, that would The dementia figures are staggering and they escalate
otherwise breakdown dopamine. dramatically as one ages. Past the age of 60, one in seven
In addition, Deprenyl also helps persons is diagnosed with dementia, but past the age of
to spike PEA (phenylethylamine) 80, there is a one in two chance of experiencing severe
levels, a function that Professor memory difficulties. The idea behind using a very low dose
Knoll now believes may be more of Deprenyl frequently, but much earlier, is that it helps to
significant than MAO-b inhibition. maintain cognitive function at higher levels.
For those interested in further
detail, we highly recommend As some neurologists have stated, “if we all live long
Professor Knoll’s book; “The brain
Professor Joseph Knoll, the
enough, we all become senile”. This
and its self” - available via the IAS
inventor of Deprenyl.
highlights the need to maintain mental
online library. agility and lucidity in later life, and this
is what makes Deprenyl a key product in
Deprenyl has been shown to help rebalance serotonin, antiaging medicine today.
norepinephrine and acetylcholine, and has been used to
treat Alzheimer’s disease and cancer. Further information regarding uses, doses
and side effects please go to:
Dopamine is a key brain chemical, responsible for drive, www.antiaging-systems.com/a2z/deprenyl.
focus and well being. It has even been cited as important htm
for a healthy libido, particularly in men.
Cyprenil® Item code: 0179
Of particular interest are Professor Knoll’s animal
experiments, demonstrating that levels of dopamine are
12ml 300mg liquid bottle $69.99
related to longevity. For example, rats given Deprenyl lived
(product cannot be shipped to the EU or Japan)
on average 40% longer than those who did not receive it. Jumex® Item code: 0035
Furthermore, the treated rats were much more active, (both
50x 5mg tablets $49.99
sexually and physically) than their counterparts, appearing
(product cannot be shipped to the EU or Japan)
to enjoy longer, healthier lives.
Selepryl® Item code: 0239
12ml 300mg liquid bottle $69.99
Dr. Knoll’s experiments
(product cannot be shipped to the EU or Japan)
showed that even the
shortest lived animals
treated with deprenyl
lived longer than the
longest lived animals
that were not treated
with deprenyl.
It is as yet unknown whether these results could be
translated to humans. It is believed that the average loss
of dopamine in the human brain is 13% per decade past
the age of 40, and naturally those with Parkinson’s disease
decline far more rapidly. Parkinson’s disease is usually
diagnosed when dopamine levels are at roughly 30% of
normal levels, with death following at 10% of normal levels.
Therefore, using low dose Deprenyl has been suggested as
a potential health and longevity agent, as well as a means of
staving off senile dementia in later life.
Order online: www.antiaging-systems.com 25
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52